Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

DCB in variable day-to-day clinical scenarios

07 Oct 2022 – From AICT-AsiaPCR 2022

In this AICT AsiaPCR 2022 session 4 cases will be discussed that will enable you to learn more about drug-coated balloons and the variable indications for their use in daily practice, or techniques for using them in different lesion settings.

DCB in variable day-to-day clinical scenarios

Abstracts - Coronary interventions - Session 4

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 8

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 5

07 Oct 2022 – From AICT-AsiaPCR 2022

Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore

06 Oct 2022 – From AICT-AsiaPCR 2022

Abstracts - Coronary interventions - Session 1

06 Oct 2022 – From AICT-AsiaPCR 2022

What's new in treatment of stent failure - a closer look at stent restenosis and thrombosis

This session shows cases from daily practice that illustrate the problems of stent failure from a general perspective. It allows for a better understanding of the mechanisms of stent restenosis & thrombosis on the one hand, and the role of DCBs on the other.

What's new in treatment of stent failure -  a closer look at stent restenosis and thrombosis

15-month results of the MASTER DAPT trial

01 Sep 2022

Alex Sticchi provides his take on the final results of the MAnagement of high bleeding risk patients post bioresorbable polymer coated STEnt implantion with an abbReviated versus prolonged DAPT regimen

Alessandro Sticchi

Author

Alessandro Sticchi
15-month results of the MASTER DAPT trial

Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

30 Aug 2022

The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...

Nicola Ryan

Reviewer

Nicola Ryan
A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

Dealing with complex and unique coronary cases

To gain insight on managing difficult and unusual coronary conditions, view these cases on: balloons, drills and shocks, a novel technique to manage large multiple mycotic aneurysms, rota-stenosis, left main longitudinal compression and many more!

Dealing with complex and unique coronary cases